Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2024-05-24
2024-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Performance of Two Soft Toric Contact Lenses
NCT05633082
A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses
NCT06438601
Bilateral Dispensing Study of Fanfilcon A Toric Versus Enfilcon A Toric Lenses
NCT02423109
Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere
NCT06400914
Clinical Evaluation of Proclear Toric and Biofinity Toric
NCT06431061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lens A (ocufilcon D)
All participants will wear lens A for 15 minutes (Period 1).
Lens A (ocufilcon D)
15 minutes of daily wear
Lens B (fanfilcon A)
All participants will wear lens B for 15 minutes (Period 2).
Lens B (fanfilcon A)
15 minutes of daily wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lens A (ocufilcon D)
15 minutes of daily wear
Lens B (fanfilcon A)
15 minutes of daily wear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has had a self-reported visual exam in the last two years.
* Is an adapted soft contact lens wearer.
* Is not a habitual wearer of either study lens.
* Has a contact lens spherical prescription between +5.00 to -9.00 (inclusive) best corrected visual acuity of 20/30 or better in either eye.
* Have contact lens prescription of no less than -0.75D of astigmatism and no more than -2.25D in both eyes.
* Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
* Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
* Has clear corneas and no active ocular disease.
* Has read, understood and signed the informed consent letter.
* Patient contact lens refraction should fit within the available parameters of the study lenses.
* Is willing to comply with the wear schedule (at least 5 days per week, \>8 hours/day assuming there are no contraindications for doing so).
* Is willing to comply with the visit schedule.
Exclusion Criteria
* Has a spectacle cylinder less than -0.75D or more than -2.50D of cylinder in either eye.
* Slit lamp findings that would contraindicate contact lens wear such as:
1. Pathological dry eye or associated findings
2. Pterygium, pinguecula, or corneal scars within the visual axis
3. Neovascularization \> 0.75 mm in form of the limbus
4. Giant papillary conjuctivitis (GCP) worse than grade 1
5. Anterior uveitis or iritis (past or present)
6. Seborrheic eczema, seborrheic conjunctivitis
7. History of corneal ulcers or fungal infections
8. Poor personal hygiene
9. Has a known history of corneal hypoesthesia (reduced corneal sensitivity)
10. Has aphakia, keratoconus or a highly irregular cornea.
11. Has Presbyopia or has dependence on spectacles for near work over the contact lenses.
12. Has undergone corneal refractive surgery.
13. Is participating in any other type of eye related clinical or research study.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ruben Guerrero, MSc, FIACLE
Role: PRINCIPAL_INVESTIGATOR
National Autonomous University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consultorio Optométrico Queretaro
Mexico City, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-157
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.